However, as we were discussing above, that doesn't necessarily mean the total effect was greater
In pooled STEP trial data for semaglutide 2.4 mg: Nausea occurred in ~44% of participants Vomiting in ~24% Symptoms were most common during dose escalation Meals such as burgers, fried foods, and fast-food combinations are more likely to cause these symptoms than smaller, balanced meals
But, while Ozempic is FDA-approved, compounded semaglutide can still be a safe, effective alternative if its prepared in a high-quality, sterile environment like USP-800 compliant compounding facilities
1 depicts the early and persistent reduction in insulin and carbohydrate intake with semaglutide
Bauer-Marinovic, M., Taugner, F., Florian, S